NYSE American - Nasdaq Real Time Price • USD
Stereotaxis, Inc. (STXS)
As of 1:44 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.06 | -0.06 | -0.23 | -0.17 |
| Low Estimate | -0.07 | -0.07 | -0.27 | -0.26 |
| High Estimate | -0.06 | -0.05 | -0.18 | -0.04 |
| Year Ago EPS | -0.07 | -0.07 | -0.27 | -0.23 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 7M | 7.02M | 30.6M | 43.54M |
| Low Estimate | 6.8M | 5.9M | 29.5M | 33.2M |
| High Estimate | 7.2M | 7.7M | 32.1M | 53.9M |
| Year Ago Sales | 6.62M | -- | 26.77M | 30.6M |
| Sales Growth (year/est) | 5.70% | -- | 14.30% | 42.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.06 | -0.07 | -0.06 | -0.07 |
| EPS Actual | -0.07 | -0.07 | -0.07 | -0.07 |
| Difference | -0.01 | 0 | -0.01 | 0 |
| Surprise % | -16.70% | 0.00% | -16.70% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.06 | -0.06 | -0.23 | -0.17 |
| 7 Days Ago | -0.06 | -0.06 | -0.23 | -0.17 |
| 30 Days Ago | -0.06 | -0.06 | -0.23 | -0.17 |
| 60 Days Ago | -0.07 | -0.06 | -0.26 | -0.13 |
| 90 Days Ago | -0.07 | -0.06 | -0.26 | -0.13 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | STXS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 14.30% | -- | -- | 1.50% |
| Next Qtr. | 14.30% | -- | -- | 11.40% |
| Current Year | 14.80% | -- | -- | 5.20% |
| Next Year | 26.10% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Lake Street: Buy to Buy | 3/5/2024 |
| Reiterates | Roth MKM: Buy to Buy | 3/5/2024 |
| Initiated | Roth MKM: Buy | 1/10/2024 |
| Maintains | Piper Sandler: Overweight | 3/6/2023 |
| Maintains | Lake Street: Buy | 3/6/2023 |
| Maintains | B. Riley Securities: Buy | 3/6/2023 |
Related Tickers
ANGO AngioDynamics, Inc.
5.82
-0.94%
ATRC AtriCure, Inc.
22.71
-1.50%
MBOT Microbot Medical Inc.
0.8858
-0.59%
EKSO Ekso Bionics Holdings, Inc.
1.2200
+3.39%
HBIO Harvard Bioscience, Inc.
3.6700
-0.54%
AVGR Avinger, Inc.
3.9100
+5.79%
OTCFF Ocumetics Technology Corp.
0.2100
0.00%
SRT.MU Sartorius AG
229.00
-1.29%
GMVDF G Medical Innovations Holdings Ltd
0.0200
+40.00%
546.SI Medtecs International Corporation Limited
0.1300
-1.52%